Sioux Falls, SD, October 19, 2026 —

Kristi Egland, an associate professor at the University of South Dakota and co-founder of Poly Solutions LLC in Sioux Falls, has received an award from the Haarberg 3D Research Center, according to the information provided about the recognition.

Egland’s research focuses on advancing cancer therapies through the development of polyclonal antibodies. The approach is inspired by the human immune system and is intended to support the creation of more effective treatments with fewer side effects.

The summary of the award does not specify its name, when it was presented, or the criteria used to select Egland. It also does not identify the award’s monetary value, if any, or describe whether the recognition includes research funding or other support. The center’s announcement and further details about the award were not provided.

Egland’s personal experience with triple-negative breast cancer has significantly influenced her dedication to this translational research, the summary says. It does not provide further details about her diagnosis or treatment, and no additional personal information is included here.

The available information does not describe particular antibody candidates, clinical trials, study results or treatments developed through Egland’s work. It also does not state when the research began or provide a timeline for future developments. Accordingly, the award recognizes Egland and her research focus, but the details provided do not establish specific clinical outcomes or the status of any treatment.

Egland’s roles at the University of South Dakota and Poly Solutions LLC, along with her research focus and personal connection to the subject, are the key details accompanying the recognition. Further information about the award and the research was not included in the summary.


Story summarized from the original created by Submitted on siouxfalls.business, see more information here.

Media gallery

About The Author
SignalNewsAI